K7DSU6 (K7DSU6_PANTR) Pan troglodytes (Chimpanzee)

non-specific serine/threonine protein kinase UniProtKBInterProInteractive Modelling

545 aa; Sequence (Fasta) ; 5 identical sequences: Homo sapiens: Q13153; Pongo abelii: A0A2J8V0U5; Pan troglodytes: A0A6D2X6T7; Gorilla gorilla gorilla: G3RY99; Nomascus leucogenys: A0A2I3H6Y7

Available Structures

32 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1 Heteromer
Q13153;
78-542
10028×IOD;
Crystal structure of human RAC3 in complex with CRIB domain of human p21-activated kinase 1 (PAK1) Heteromer
P60763; Q13153;
74-97
100MG;GCP;GOL;
beta PIX-SH3 complexed with an atypical peptide from alpha-PAK Heteromer
Q13153; Q14155;
183-204
100
Pak1 peptide bound LC8 Heteromer
Q13153; Q24117;
213-221
100
Structure of unphosphorylated PAK1 kinase domainhomo-2-mer250-545
98.58MG;ANP;
Serine/threonine-protein kinase PAK1 complexed with a dibenzodiazepine: identification of an allost…homo-2-mer250-543
100.04PV;GOL;
The Crystal Structure of PAK1 kinase domain from Biortus.monomer249-543
99.31
Crystal structure of PAK1 in complex with an inhibitor compound 5monomer250-544
99.3259N;
Crystal structure of PAK1 in complex with an inhibitor compound G-5555monomer250-544
99.3259T;
Crystal structure of P21-activated kinase 1 (PAK1) in complex with compound 9monomer251-545
99.286BZ;
Crystal structure of PAK1 kinase domain with the ruthenium phthalimide complexmonomer249-542
99.660H2;
Crystal structure of PAK1 kinase domain with ruthenium complex lambda-FL172monomer249-541
99.66FLL;
Crystal Structure of PAK1 kinase domain with one point mutations (K299R)monomer249-541
99.32
Crystal Structure of PAK1 kinase domain with two point mutations (K299R, T423E)monomer249-541
98.98
Structure of phosphorylated PAK1 kinase domainmonomer250-542
99.32
PAK1 complex with ST2001monomer249-541
98.981ST;
Crystal structure of PAK1 kinase domain in complex with FRAX597 inhibitormonomer249-541
99.66XR1;CL;
Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036monomer249-541
99.6659U;DMS;
Crystal structure of PAK1 kinase domain with ruthenium complex DW1monomer249-541
99.66DW1;
Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitorsmonomer249-541
99.327KC;
Crystal structure of the kinase domain of human PAK1 in complex with compound 15monomer250-542
98.92K0;
Crystal structure of P21 activated kinase 1 in complex with an inhibitor compound 4monomer249-541
99.654T3;SO4;
Structure of phosphorylated PAK1 kinase domain in complex with ATPmonomer250-541
99.31ATP;MG;
Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29monomer251-542
99.654T6;SO4;
P21-activated kinase 1 in complex with a 4-azaindole inhibitormonomer251-542
99.65C7Y;SO4;
Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17monomer251-542
99.654T5;SO4;
Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitorsmonomer251-542
99.312OL;
PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)p…monomer249-539
100.04OR;
PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepinemonomer254-542
100.04OQ;
Pak1 in complex with bis-anilino pyrimidine inhibitormonomer254-542
98.96IPV;
Pak1 in complex with 7-azaindole inhibitormonomer255-542
98.84IPW;
The crystal structure of PAK1 with the inhibitor GW8510monomer257-542
99.62107;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6fd3.1.Amonomer0.83248-543
ADP;94.95
6byr.1.Amonomer0.65195-509
27.51